News and Views
Abstract
Hypertension is one of the common medical problems encountered in 10% of all pregnancies. Hypertensive disorders of pregnancy include pre-eclampsia, eclampsia, chronic hypertension and gestational hypertension.[1] Of these disorders, Pre-Eclampsia (PE) accounts for 70% of the hypertensive disorders in pregnancy with a major negative impact on pregnancy outcome as well as maternal and fetal morbidity and mortality. Though anti-hypertensive drugs are used in the management of pregnancy-induced hypertension, termination of pregnancy alone offers a complete cure.[2] In developing countries, like India the incidence of preeclampsia ranges from 1.8% to 16.7% which is 7 times higher than the worldwide incidence which is 3% to 8%.[3] Poor knowledge about the medical care available for pregnant women and poverty have been attributed to the high incidence of the disease.[4] Preeclampsia is one of the important health problems in pregnant women with potential fetal complications such as growth retardation, prematurity, low birth weight and death.[5] Maternal complications such as HELLP (Haemolysis, Elevated Liver enzymes, Low Platelets) syndrome, cerebral edema accompanied by seizures, renal failure and death.[6] Hence optimizing healthcare for expectant mothers is crucial for achieving sustainable development goals and improving the prevention and treatment of these dangerous hypertensive disorders. Read more...
![News and Views](https://ijcep.org/public/journals/1/article_732_cover_en_US.png)
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.